Polyvinyl alcohol extrudates for improving the dissolution of main protease and reverse-transcriptase inhibitors.

Polyvinyl alcohol extrudates for improving the dissolution of main protease and reverse-transcriptase inhibitors.

The aim of this work was to improve the solubility of various anti-HIV APIs extruding them with polyvinyl alcohol to allow a reduction in patient drug burden. There are no previously known cases of successful use of this polymer to improve the solubility of APIs using a convenient industrial technol...

Full description

Bibliographic Details
Main Authors:	Sergey A Zolotov, Natalia B Demina, Igor A Dain, Anna S Zolotova, Grigorii A Buzanov, Vasilii M Retivov, Alexander M Cheremisin
Format:	Article
Language:	English
Published:	International Pharmaceutical Excipients Council 2022-03-01
Series:	Journal of Excipients and Food Chemicals
Online Access:	https://jefc.scholasticahq.com/article/33911-polyvinyl-alcohol-extrudates-for-improving-the-dissolution-of-main-protease-and-reverse-transcriptase-inhibitors

Similar Items

Complex dispersions of poloxamers and mesoporous carriers with ibrutinib
by: Igor A. Dain, et al.
Published: (2022-11-01)

Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
by: S. A. Zolotov, et al.
Published: (2022-05-01)

Study of the Technological Methods Effect on Dissolution of the X-ray Amorphous Efavirenz-mesoporous Carrier System
by: S. A. Zolotov, et al.
Published: (2022-09-01)

HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner
Published: (2014-01-01)

HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.
by: Gilles Mirambeau, et al.
Published: (2007-08-01)

HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner.
Published: (2014-01-01)

HIV-1 subtype B protease and reverse transcriptase amino acid covariation.
by: Soo-Yon Rhee, et al.
Published: (2007-05-01)

The Effect of Solvents and Drying Temperature on the Physicochemical Properties of Darunavir and Darunavir Ethanolate Substances
by: S. A. Zolotov, et al.
Published: (2021-02-01)

Study of the physicochemical properties of the etravirine substance
by: S. A. Zolotov, et al.
Published: (2021-11-01)

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.
by: Mark A Winters, et al.
Published: (2012-01-01)

Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
by: Rafal Mostowy, et al.
Published: (2012-01-01)

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
by: Supang A. Martin, et al.
Published: (2021-08-01)

A reverse transcriptase ribozyme
by: Biswajit Samanta, et al.
Published: (2017-09-01)

Extruded cornstarch-glycerol-polyvinyl-polyvinyl alcohol blends : mechanical properties, morphology and biodegradability /
by: 387465 Mao, Lijun

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
by: Bonté Frédéric, et al.
Published: (2009-09-01)

Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT)
by: Jerry Joe E. K. Harrison, et al.
Published: (2021-07-01)

Prediction of mutational tolerance in HIV-1 protease and reverse transcriptase using flexible backbone protein design.
by: Elisabeth Humphris-Narayanan, et al.
Published: (2012-01-01)

Distinguishing functional amino acid covariation from background linkage disequilibrium in HIV protease and reverse transcriptase.
by: Qi Wang, et al.
Published: (2007-08-01)

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
by: Rami Kantor, et al.
Published: (2005-04-01)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
by: Dinesh Bure, et al.
Published: (2015-02-01)

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings
by: Sontaga Manyana, et al.
Published: (2023-02-01)

Telomerase reverse transcriptase and neurodegenerative diseases
by: Xin Yu, et al.
Published: (2023-03-01)

THE DEMOGRAPHIC PROFILE OF HIV-1 DRUG RESISTANCE PROTEASE/ REVERSE TRANSCRIPTASE (PR/RT) CASES IN MALAYSIA FROM 2020-2022
by: S. Abdullah, et al.
Published: (2023-05-01)

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
by: Nicolas Tardiota, et al.
Published: (2024-01-01)

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
by: Adetayo Emmanuel Obasa, et al.
Published: (2020-03-01)

Improving fold resistance prediction of HIV-1 against protease and reverse transcriptase inhibitors using artificial neural networks
by: Olivier Sheik Amamuddy, et al.
Published: (2017-08-01)

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

Asymmetric conformational maturation of HIV-1 reverse transcriptase
by: Xunhai Zheng, et al.
Published: (2015-06-01)

Reverse transcriptase inhibitors from curcuma phaeocaulis/
by: Hou, Yu-Chi, et al.

The regulations of telomerase reverse transcriptase (TERT) in cancer
by: Mingdi Liu, et al.
Published: (2024-01-01)

Comprehensive phylogenetic analysis of bacterial reverse transcriptases.
by: Nicolás Toro, et al.
Published: (2014-01-01)

The Reverse Transcriptases Associated with CRISPR-Cas Systems
by: Nicolás Toro, et al.
Published: (2017-08-01)

Telomerase reverse transcriptase gene amplification in hematological malignancies
by: Amany H. Abdelrahman, et al.
Published: (2019-11-01)

Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1
by: Dilsha Siddiqui, et al.
Published: (2023-01-01)

Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1.
by: Dilsha Siddiqui, et al.
Published: (2023-01-01)

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Published: (2013-01-01)

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
by: Farah Bokharaei-Salim, et al.
Published: (2020-01-01)

HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies
by: Chanin Sillapachaiyaporn, et al.
Published: (2020-07-01)

Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
by: Smeulders Liesbeth, et al.
Published: (2010-10-01)

The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
by: Walter A. Scott, et al.
Published: (2010-01-01)